Interactions between synthetic drugs used in treatment of selected central nervous system disorders and dietary supplements and herbal drugs

被引:0
作者
Zablocka-Slowinska, Katarzyna [1 ]
Jawna, Katarzyna [1 ]
Biernat, Jadwiga [1 ,2 ]
机构
[1] Wroclaw Med Univ, Katedra Zaklad Bromatol & Dietetyki, Wroclaw, Poland
[2] Zaklad Zywienia Czlowieka UP Wroclawiu, Wroclaw, Poland
关键词
dietary supplement; herbal drug; interactions; CNS disorders; GINKGO-BILOBA EXTRACT; ST-JOHNS-WORT; PLANTAGO-OVATA HUSK; HYDRASTIS-CANADENSIS; FOLIC-ACID; KAVA-KAVA; PHARMACOKINETICS; PHARMACODYNAMICS; TOLBUTAMIDE; GOLDENSEAL;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The risk of interaction between dietary supplements, herbal drugs and synthetic drugs increases when patients are treated chronically, e.g. due to impairment of central nervous system (CNS) - depression, psychotic disorders, Parkinson's and Alzheimer's diseases. On the basis of scientific literature, there was shown that simultaneous intake of antidepressants, antipsychotic drugs and herbal drugs or dietary supplements containing: St. John's wort, valerian root, ginkgo biloba leaf, hops, and food ingredients: dietary fiber or folic acid, may lead to interactions. Dietary fiber supplementation should be applied carefully during treatment of Parkinson's disease and in case of Alzheimer disease treatment - supplements containing ginkgo biloba leaf can increase the risk of interaction. Knowledge of these interactions is essential in effective treatment of this illness. However this area of science should be verified constantly due to growing number of new products registered as a supplements - often with complex composition.
引用
收藏
页码:487 / 498
页数:12
相关论文
共 52 条
[1]   No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract [J].
Arold, G ;
Donath, F ;
Maurer, A ;
Diefenbach, K ;
Bauer, S ;
Henneicke-von Zepelin, HH ;
Friede, M ;
Roots, I .
PLANTA MEDICA, 2005, 71 (04) :331-337
[2]   Folic acid administration produces an antidepressant-like effect in mice: Evidence for the involvement of the serotonergic and noradrenergic systems [J].
Brocado, Patricia S. ;
Budni, Josiane ;
Kaster, Manuella P. ;
Santos, Adair R. S. ;
Rodrigues, Ana Lucia S. .
NEUROPHARMACOLOGY, 2008, 54 (02) :464-473
[3]   Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl beta-carboline-3-carboxylate on social behavior of the rat [J].
Chermat, R ;
Brochet, D ;
DeFeudis, FV ;
Drieu, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 56 (02) :333-339
[4]  
Cupp MJ, 1999, AM FAM PHYSICIAN, V59, P1239
[5]   The hydrosoluble fiber Plantago ovata husk improves levodopa (with carbidopa) bioavailability after repeated administration [J].
Diez, M. Jose ;
Garcia, Juan J. ;
Prieto, Carlos ;
Fernandez, Nelida ;
Sahagun, Ana ;
Sierra, Matilde .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 271 (1-2) :15-20
[6]   Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers [J].
Donovan, JL ;
DeVane, CL ;
Chavin, KD ;
Wang, JS ;
Gibson, BB ;
Gefroh, HA ;
Markowitz, JS .
DRUG METABOLISM AND DISPOSITION, 2004, 32 (12) :1333-1336
[7]  
Drozak Jakub, 2006, Postepy Hig Med Dosw (Online), V60, P498
[8]   Hydrosoluble fiber (Plantago ovata husk) and levodopa II:: Experimental study of the pharmacokinetic interaction in the presence of carbidopa [J].
Fernandez, N ;
Carriedo, D ;
Sierra, M ;
Diez, MJ ;
Sahagun, A ;
Calle, A ;
Gonzalez, A ;
Garcia, JJ .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (05) :505-509
[9]  
GALUSZKO M, 2005, PSYCHIATRIA, V2, P93
[10]  
Gardiner P, 2008, AM FAM PHYSICIAN, V77, P73